I would like to know US, EU, Asia-Pacific and/or worldwide taxane
sales by indication (ovarian, breast, lung, etc) for 2004 forecasted
through 2014 (or over as long of a period as you can find data for). 
For example, a good answer would be: in year 2004 taxane sales of
breast cancer was $1 billion in the US; $600M in the EU and $2.1b
Worldwide (and then the same for ovarian, lung, and prostate for the
other years).  If you can find out sales split out by Taxol and
Taxotere (the two main taxanes), all the better, but that level of
detail is
not necessary.  If you cannot find sales number for all the regions,
US and worldwide are probably the most important.  I also need sources for
your answer to make sure they are valid and supportable.  Thanks!

---

Request for Question Clarification by belindalevez-ga on 28 Aug 2005 09:10 PDT

<I have found several market research reports that cost several
thousand dollars. Are references to these of any use?

It is possible to calculate estimates for world sales for taxenes for
2004, 2009 and 2014. I also have figures for World sales for taxol for
2004, 2005, world taxotere sales for 2004 and 2010, the percentage of
taxotere sales for lung and breast cancer. US breast cancer taxane
sales for 2004 and European breast cancer taxene sales for 2004,
percentages for the sales of oncology drugs in the US, Japan and EU.

In the public domain, the information for ovarian cancer is scarce.
However I have found an analysis of taxol sales for 1999 that gives a
percentage breakdown of sales for lung, breast and ovarian cancers
that may be helpful in calculating an estimate of sales.

Is any of this information of any help?>